Future research direction of portal hypertension based on Baveno VII

分享到

Link by DOI

作者单位: Division of Gastroenterology and Hepatology，Sichuan University-University of Oxford Huaxi Joint Centre for Gastrointestinal Cancer，West China Hospital，Sichuan University，Chengdu，Sichuan 610041，China；Department of Gastroenterology and Hepatology，Shandong Provincial Hospital Affiliated to Shandong First Medical University，Jinan，Shandong 250021，China；Division of Gastroenterology and Hepatology，Sichuan University-University of Oxford Huaxi Joint Centre for Gastrointestinal Cancer，West China Hospital，Sichuan University，Chengdu，Sichuan 610041，China；Barcelona Hepatic Hemodynamic Laboratory，Liver Unit，Hospital Clínic，Clínic Barcelona，ERN-RareLiver (Health Care Provider of the European Reference Network on Rare Liver Disorders)，CSUR Centro de referencia del Sistema Nacional de Salud en Enfermedad Hepática Vascular Compleja en adultos，Barcelona，Spain；FRCB-IDIBAPS (Fundació de Recerca Clínic Barcelona-Institut d’Investigacions Biomèdiques August Pi i Sunyer)，Barcelona，Spain；CIBEREHD (Centro de Investigación Biomédica en Red Enfermedades Hepáticas y Digestivas)，Madrid，Spain；AGAUR SGR2021 01115 Catalonia，Spain；Medicine Department，Faculty of Medicine and Health Science，Universitat de Barcelona，Barcelona，Catalonia，Spain

关键词: Cirrhosis Portal hypertension Variceal bleeding Decompensation Recompensation Transjugular intrahepatic portosystemic shunt

摘要: The Baveno Cooperation is a consortium of internationally renowned experts committed to setting standards for the clinical management of patients with advanced chronic liver disease, with a particular emphasis on complications related to portal hypertension. Updated every five years and endorsed by major scientific societies, the Baveno recommendations have significantly influenced clinical practice and improved patient outcomes worldwide. The latest Baveno consensus, Baveno VII, provided a seri...更多; The Baveno Cooperation is a consortium of internationally renowned experts committed to setting standards for the clinical management of patients with advanced chronic liver disease, with a particular emphasis on complications related to portal hypertension. Updated every five years and endorsed by major scientific societies, the Baveno recommendations have significantly influenced clinical practice and improved patient outcomes worldwide. The latest Baveno consensus, Baveno VII, provided a series of recommendations that have shifted our understanding of chronic liver disease and portal hypertension and profoundly shaped clinical practice. However, many areas of research remain to be explored in the short to intermediate term to enable a more personalized medicine approach. This review highlights some of the most relevant advancements introduced in Baveno VII and discusses future challenges.收起

列表公用js 卡片页统计

看了本文的还看了

相同作者单位文献